Alvotech and Bioventure gain approval for Humira biosimilar in Egypt

Alvotech and Bioventure received the Egyptian Drug Authority's approval to produce and supply AVT02 (adalimumab), a biosimilar for Humira.

Aug 30, 2023 - 20:00

Alvotech and Bioventure gain approval for Humira biosimilar in Egypt

Alvotech and Bioventure received the Egyptian Drug Authority's approval to produce and supply AVT02 (adalimumab), a biosimilar for Humira.

Read the original article

Tags:

Previous Article

EC grants approval to Merck’s Keytruda for gastric cancer

Ipilimumab by Bristol-Myers Squibb for Metastatic Transitional (Urothelial) Trac...

What's Your Reaction?

0

Like

0

Dislike

0

Love

0

Funny

0

Angry

0

Sad

0

Wow

Related Posts

Patients’ social needs often get lost in health records. Generative AI could help

Patients’ social needs often get lost in health records...

Jan 12, 2024

Candor on gene therapy, Abiomed is warned, & BTK success in MS

Candor on gene therapy, Abiomed is warned, & BTK succes...

Oct 16, 2023

Risk adjusted net present value: What is the current va...

Nov 18, 2023